• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENTS CO. LT SIUI APOGEE 2300 DIGITAL COLOR DOPPLER ULTRASOUND IMAGING SYSTEM; ULTRASONIC PULSED DOPPLER IMAGING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENTS CO. LT SIUI APOGEE 2300 DIGITAL COLOR DOPPLER ULTRASOUND IMAGING SYSTEM; ULTRASONIC PULSED DOPPLER IMAGING SYSTEM Back to Search Results
Model Number APOGEE 2300
Device Problem Use of Device Problem (1670)
Patient Problem Perforation (2001)
Event Date 10/20/2021
Event Type  Injury  
Event Description
On (b)(6) 2021, procept biorobotics corporation (procept), the us importer of the apogee 2300 digital color doppler ultrasound imaging system, became aware that a patient underwent an aquablation procedure for symptomatic benign prostatic hyperplasia (bph).The patient presented with several large hemorrhoids prior to the aquablation procedure.Post aquablation procedure, upon removal of the ecbp-1 trus probe, a component of the apogee 2300 digital color doppler ultrasound imaging system, blood was observed on the probe.The patient went into the pacu and kept overnight for observation.On (b)(6) 2021, procept was notified that the patient had rectal perforation and was placed with a temporary colostomy bag to be kept for two (2) months (per importer's instructions for use, rectal perforation is a perioperative risk of the aquablation procedure).No product malfunction was reported.
 
Manufacturer Narrative
Additional manufacturer narrative: root cause of reported event has not yet been established.Investigation is currently in process.
 
Event Description
On (b)(6) 2021, (b)(4), the us importer of the apogee 2300 digital color doppler ultrasound imaging system, became aware that a patient underwent an aquablation procedure for symptomatic benign prostatic hyperplasia (bph).The patient presented with several large hemorrhoids prior to the aquablation procedure.Post aquablation procedure, upon removal of the ecbp-1 trus probe, a component of the apogee 2300 digital color doppler ultrasound imaging system, blood was observed on the probe.The patient went into the pacu and kept overnight for observation.On (b)(6) 2021, (b)(4) was notified that the patient had rectal perforation and was placed with a temporary colostomy bag to be kept for two (2) months (per importer's instructions for use, rectal perforation is a perioperative risk of the aquablation procedure).No product malfunction was reported.
 
Manufacturer Narrative
Additional manufacturer narrative: root cause of reported event has not yet been established.Investigation is currently in process.
 
Manufacturer Narrative
H.10 additional manufacturer narrative: a review of the device history record (dhr) for apogee 2300 digital color doppler ultrasound imaging system (sn:(b)(6)) and its component ecbp-1 endocavity biplane ultrasound probe related to the reported event was performed, which confirmed that there were no nonconformance, failures, discrepancies or missed steps during the manufacturing process that could be related to the reported event.The review indicated that the device met all design and manufacturing specifications when released for distribution.No similar complaint to the reported event was found after reviewing the post-marketing surveillance data of the device.The review of the operation manual for the apogee 2300 device (ifu) found that it has covered the related safety instruction: 1.6 safety l) when performing the rectal ultrasound exam, be gentle in the movement.Do not perform violent operation, otherwise it may cause risks of perforation of the rectal wall, damage to the anus and perianal tissues, damage to the rectal mucosa or bleeding.A similar complaint review was conducted by procept, the importer, for a 12-month period, whichconfirmed four (4) similar events have been reported during the searched period.In summary, the root cause for the reported event could not be determined.The user manual of the apogee 2300 device lists rectal perforation as a potential risk of the procedure.Based on the review of dhr, post-marketing data and ifu, the event is considered not to be device related.The information received determined that the rectal perforation was not related to the siui apogee 2300 device.Submission of this report does not constitute an admission that the manufacturer's products caused or contributed to the reported event.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SIUI APOGEE 2300 DIGITAL COLOR DOPPLER ULTRASOUND IMAGING SYSTEM
Type of Device
ULTRASONIC PULSED DOPPLER IMAGING SYSTEM
Manufacturer (Section D)
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENTS CO. LT
77 jinsha road
shantou, guangdong 51504 1
CH  515041
MDR Report Key12849135
MDR Text Key285987842
Report Number3012977056-2021-00095
Device Sequence Number1
Product Code IYN
UDI-Device Identifier06938396423001
UDI-Public0106938396423001
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberAPOGEE 2300
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA08/15/2022
Distributor Facility Aware Date07/28/2022
Event Location Hospital
Date Report to Manufacturer08/15/2022
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/19/2021
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received08/15/2022
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient SexMale
-
-